A Randomized Phase Ii Trial Of Temozolomide (Tmz) And Bevacizumab (Bev) Or Nab-Paclitaxel (Nab-P)/Carboplatin (Cbdca) And Bevacizumab (Bev) In Patients With Unresectable Stage Iv Metastatic Melanoma: A North Central Cancer Treatment Group Study (N0775).
JOURNAL OF CLINICAL ONCOLOGY（2011）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要